Calmark
Calmark relaunches Neo-Bilirubin in Finland
Calmark Sweden Ab already has a distributor agreement with Triolab Oy in Finland. The collaboration has now intensified after Calmark's product Neo-Bilirubin can also be used for capillary sampling. The product will be exhibited at a fair in Helsinki during the week.
"According to the distributor, a number of hospitals and clinics have shown interest in using a near-patient solution for bilirubin tests on newborns," comments CEO Anna Söderlund. "We are very happy about the committed work that Triolab does."
| Datum | 2024-02-05, kl 11:50 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!